NPC Healthbiz Weekly

NPC Healthbiz Weekly

Home
Podcast
Archive
About
mRNA vaccines expand beyond Covid-19 into oncology and infectious diseases
Clinical research surges as mRNA technology shifts toward cancer treatment, rare diseases, and global health threats (Issue #335, 1000 words, 5 minutes)
 • 
Cristela Tello Ruiz
From faster timelines to smarter clinical trials — How AI is revolutionizing drug discovery
The value lies in enhancing patient recruitment, optimizing study design, and enabling real-time adjustments (Issue #334, 1,300 words, 6.5 minutes)
 • 
Cristela Tello Ruiz
Tech is transforming the pharma industry, speeding drug discovery and personalizing medicine
It's all about AI, and much more. Get ready for the next waves of disruptive technologies (Issue #333, 1,371 words, 6.5 minutes)
 • 
Cristela Tello Ruiz
Revolutionizing chronic care: The next frontier in precision medicine
From Alzheimer’s breakthroughs to diabetes and cardiovascular innovations, cutting-edge therapies are reshaping treatment paradigms—and the…
 • 
Cristela Tello Ruiz

May 2025

First AbbVie Biotech Innovators Award goes to Neuropeutics
Startup focused on neurodegenerative disease research to receive support from the SpinUp incubator at the University of Toronto Mississauga (Issue #332…
 • 
Cristela Tello Ruiz
Feds looking for more transparency in drug pricing
Proposed pricing reforms put emphasis on clinical effectiveness and real-world outcomes (Issue #331, 1,200 words, 6 minutes)
 • 
Cristela Tello Ruiz
Pharma regulation 2025: Digital transformation, AI, and global harmonization reshape the compliance landscape
Regulatory agencies worldwide are embracing cloud technologies and AI to streamline approvals, strengthen data integrity, and accelerate innovation…
 • 
Cristela Tello Ruiz
Pharma M&A: What's the global landscape for 2025?
Technological innovation and favourable market conditions drive a new wave of high-stakes mergers and acquisitions in the life sciences (Issue #329…
 • 
Cristela Tello Ruiz

April 2025

Tariffs and the effect on Canadian pharma
Paul Levesque provides his take on innovation in biopharma, the effects of tariffs on supply chains and pharma manufacturing, and cross-border…
 • 
Cristela Tello Ruiz
S14 E01 Dr. Bettina Hamelin and The Role of Innovative Medicines Canada
Dr.
 • 
Jeremy Visser
30:25
Serving women’s health in the specialty pharma sector
Mark Nawacki gives insights into starting a specialty pharma business, therapeutics for women’s health, and the shift to more personalized medicines in…
 • 
Cristela Tello Ruiz
Lisa Mullet on the importance of diversity in shaping healthcare
Sumitomo Pharma Canada’s GM says stepping out of your comfort zone is the way to further your career (Issue #327, 1,193 words, 5.5 minutes)
 • 
Cristela Tello Ruiz
© 2025 Chronicle Information Resources Ltd.
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture